Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boguniewicz

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Investigation|January 1, 1995
Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitisD L Bratton, Q Hamid, M Boguniewicz, et al.
The Journal of Allergy and Clinical Immunology|January 1, 1995
The effects of nebulized recombinant interferon-gamma in asthmatic airwaysM Boguniewicz, R J Martin, D Martin, et al.
The Journal of Allergy and Clinical Immunology|November 5, 1998
A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study GroupM Boguniewicz, V C Fiedler, S Raimer, et al.
The American Journal of Medicine|April 1, 1990
Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levelsM Boguniewicz, H S Jaffe, A Izu, et al.
The American Review of Respiratory Disease|December 1, 1993
The effects of inhaled interferon gamma in normal human airwaysR J Martin, M Boguniewicz, J E Henson, et al.
The Journal of Allergy and Clinical Immunology|May 16, 2000
Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitisR A Taha, E M Minshall, D Y Leung, et al.
The British Journal of Dermatology|June 19, 2007
Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trialJ M Spergel, M Boguniewicz, A S Paller, et al.
The British Journal of Dermatology|April 12, 2019
Validation of five patient-reported outcomes for atopic dermatitis severity in adultsJ I Silverberg, D J Margolis, M Boguniewicz, et al.
The British Journal of Dermatology|October 12, 2021
Conjunctivitis in adult patients with moderate-to-severe atopic dermatitis: results from five tralokinumab clinical trialsA Wollenberg, L A Beck, M de Bruin Weller, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 1, 1993
Treatment of steroid-dependent asthma with recombinant interferon-gammaM Boguniewicz, L C Schneider, H Milgrom, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Investigation|January 1, 1995
Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitisD L Bratton, Q Hamid, M Boguniewicz, et al.
The Journal of Allergy and Clinical Immunology|January 1, 1995
The effects of nebulized recombinant interferon-gamma in asthmatic airwaysM Boguniewicz, R J Martin, D Martin, et al.
The Journal of Allergy and Clinical Immunology|November 5, 1998
A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study GroupM Boguniewicz, V C Fiedler, S Raimer, et al.
The American Journal of Medicine|April 1, 1990
Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levelsM Boguniewicz, H S Jaffe, A Izu, et al.
The American Review of Respiratory Disease|December 1, 1993
The effects of inhaled interferon gamma in normal human airwaysR J Martin, M Boguniewicz, J E Henson, et al.
The Journal of Allergy and Clinical Immunology|May 16, 2000
Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitisR A Taha, E M Minshall, D Y Leung, et al.
The British Journal of Dermatology|June 19, 2007
Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trialJ M Spergel, M Boguniewicz, A S Paller, et al.
The British Journal of Dermatology|April 12, 2019
Validation of five patient-reported outcomes for atopic dermatitis severity in adultsJ I Silverberg, D J Margolis, M Boguniewicz, et al.
The British Journal of Dermatology|October 12, 2021
Conjunctivitis in adult patients with moderate-to-severe atopic dermatitis: results from five tralokinumab clinical trialsA Wollenberg, L A Beck, M de Bruin Weller, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 1, 1993
Treatment of steroid-dependent asthma with recombinant interferon-gammaM Boguniewicz, L C Schneider, H Milgrom, et al.
Pageof 4